Drug safety alert: IPC flags adverse reactions linked to Cefuroxime
New Delhi: The Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert for the month of April, has revealed that a cephalosporin antibiotic Cefuroxime is linked with Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome.
This came after preliminary analysis of Adverse Drug Reactions (ADRs) from the Pharmacovigilance Programme of India (PvPI) database.
Cefuroxime, like the penicillins, is a beta-lactam antibiotic. By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, it inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that cefuroxime interferes with an autolysin inhibitor.
Cefuroxime is indicated for lower & upper respiratory tract infection, UTI, gynaecological infection, skin or soft tissue infection etc. Further, the drug is indicated in the treatment of respiratory tract infections, UTI, ENT soft tissue infections etc.
Following the preliminary analysis of Adverse Drug Reactions (ADRs) from the PvPI database, it is reported that Cefuroxime can lead to Adverse Drug Reaction named Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.